12 Sept Programme

Programme 

Moderator:    Petter Björquist, VP Regenerative Medicine, Senior Principal Scientist, Cellectis

Venue:          Wallenberg konferenscentrum, ”Radiovågen”

09.00 Welcome to Western Sweden Life Science
Erik Bengtsson, head of incubator at Sahlgrenska Science Park and Christina Bergstrand, UK Trade & Investment
09.10 Examples of drug development in Western Sweden

 

  • Lavivo AB (bacterial infection )Mats Wallström, CEO
  • NovaHep (regenerative medicine, stem cells) Jan Holgersson, CEO
  • Immunicum AB (Cancer vaccines) Henrik Elofsson, COO

 
09.40

AstraZeneca R&D structure and outsourcing

Mattias Rehnberg, Global Category Manager outsourcing,  AstraZeneca R&D, Mölndal
09.50

NIHR Office for Clinical Research Infrastructure (NOCRI) 

Ravi Chan, BDM exRoche, Bayer and Abbott 

NOCRI is part of the National Institute for Health Research (NIHR), the UK’s largest public funder of health research. NOCRI can help navigate the clinical research environment and find expert researchers and world class facilities and technologies and support development of collaborative research partnerships. NIHR represent one of the most integrated clinical research systems in the world – driving research from bench to bedside for patient benefit.

Coffee Break
10.10 Short presentations from UK companies (5 MIN)
  • Aptuit, Heidi Pavliska
  • A4P Consulting, Carl Watson,
  • Orion Clinical Services Ltd, Peter MacLennan
  • Parexel Ltd, Mathias Ditzen
  • Steward Hulse, Venn Life Sciences
  • Molecular Profiles, Peter Farmer
  • Sequani Ltd, Laurence Bishop
  • Harlan Laboratories, Joanne Miller
  • Quotient Bio Research, Andrew Maitland
  • Datatrial, Lewis Baird
  • Cyprotex Discovery, Daniele Bemporad
  • Biotech Services Internationals, Jonathan Lake
  • Almac Group Ltd, Glyn Allsop
  • Pharmaterials Ltd, Chris Landeg
  • Sygnature Discovery, Paul Clewlow
11.20 Partnering meetings and networking, including lunch
13.00 End of Programme, partnering continues to 16.00